Thursday, 14 September 2017

Pfizer, Astellas prostate cancer drug succeeds key trial

(Reuters) - Pfizer Inc and Japan's Astellas Pharma Inc said on Thursday their prostate cancer drug met the main goal of a trial testing it for a more common form of the disease.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)